Targeting C-fibers for peripheral acting anti-tussive drugs

Research output: Contribution to journalReview article

Abstract

Activation of vagal C-fibers is likely involved in some types of pathological coughing, especially coughing that is associated with airway inflammation. This is because stimulation of vagal C-fibers leads to strong urge to cough sensations, and because C-fiber terminals can be strongly activated by mediators associated with airway inflammation. The most direct manner in which a given mediator can activate a C-fiber terminal is through interacting with its receptor expressed in the terminal membrane. The agonist-receptor interaction then must lead to the opening (or potentially closing) of ion channels that lead to a membrane depolarization. This depolarization is referred to as a generator potential. If, and only if, the generator potential reaches the voltage necessary to activate voltage-gated sodium channels, action potentials are initiated and conducted to the central terminals within the CNS. Therefore, there are three target areas to block the inflammatory mediator induced activation of C-fiber terminals. First, at the level of the mediator-receptor interaction, secondly at the level of the generator potential, and third at the level of the voltage-gated sodium channels. Here we provide a brief overview of each of these therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)15-19
Number of pages5
JournalPulmonary Pharmacology and Therapeutics
Volume56
DOIs
StatePublished - Jun 1 2019

Fingerprint

Unmyelinated Nerve Fibers
Cough
Fibers
Voltage-Gated Sodium Channels
Pharmaceutical Preparations
Depolarization
Chemical activation
Inflammation
Membranes
Ion Channels
Action Potentials
Electric potential

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Biochemistry, medical
  • Pharmacology (medical)

Cite this

Targeting C-fibers for peripheral acting anti-tussive drugs. / Patil, Mayur J.; Sun, Hui; Ru, Fei; Meeker, Sonya; Undem, Bradley J.

In: Pulmonary Pharmacology and Therapeutics, Vol. 56, 01.06.2019, p. 15-19.

Research output: Contribution to journalReview article

@article{9c07d3748d6c4b04bc92f92be6cf88fd,
title = "Targeting C-fibers for peripheral acting anti-tussive drugs",
abstract = "Activation of vagal C-fibers is likely involved in some types of pathological coughing, especially coughing that is associated with airway inflammation. This is because stimulation of vagal C-fibers leads to strong urge to cough sensations, and because C-fiber terminals can be strongly activated by mediators associated with airway inflammation. The most direct manner in which a given mediator can activate a C-fiber terminal is through interacting with its receptor expressed in the terminal membrane. The agonist-receptor interaction then must lead to the opening (or potentially closing) of ion channels that lead to a membrane depolarization. This depolarization is referred to as a generator potential. If, and only if, the generator potential reaches the voltage necessary to activate voltage-gated sodium channels, action potentials are initiated and conducted to the central terminals within the CNS. Therefore, there are three target areas to block the inflammatory mediator induced activation of C-fiber terminals. First, at the level of the mediator-receptor interaction, secondly at the level of the generator potential, and third at the level of the voltage-gated sodium channels. Here we provide a brief overview of each of these therapeutic strategies.",
author = "Patil, {Mayur J.} and Hui Sun and Fei Ru and Sonya Meeker and Undem, {Bradley J}",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.pupt.2019.03.002",
language = "English (US)",
volume = "56",
pages = "15--19",
journal = "Pulmonary Pharmacology and Therapeutics",
issn = "1094-5539",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Targeting C-fibers for peripheral acting anti-tussive drugs

AU - Patil, Mayur J.

AU - Sun, Hui

AU - Ru, Fei

AU - Meeker, Sonya

AU - Undem, Bradley J

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Activation of vagal C-fibers is likely involved in some types of pathological coughing, especially coughing that is associated with airway inflammation. This is because stimulation of vagal C-fibers leads to strong urge to cough sensations, and because C-fiber terminals can be strongly activated by mediators associated with airway inflammation. The most direct manner in which a given mediator can activate a C-fiber terminal is through interacting with its receptor expressed in the terminal membrane. The agonist-receptor interaction then must lead to the opening (or potentially closing) of ion channels that lead to a membrane depolarization. This depolarization is referred to as a generator potential. If, and only if, the generator potential reaches the voltage necessary to activate voltage-gated sodium channels, action potentials are initiated and conducted to the central terminals within the CNS. Therefore, there are three target areas to block the inflammatory mediator induced activation of C-fiber terminals. First, at the level of the mediator-receptor interaction, secondly at the level of the generator potential, and third at the level of the voltage-gated sodium channels. Here we provide a brief overview of each of these therapeutic strategies.

AB - Activation of vagal C-fibers is likely involved in some types of pathological coughing, especially coughing that is associated with airway inflammation. This is because stimulation of vagal C-fibers leads to strong urge to cough sensations, and because C-fiber terminals can be strongly activated by mediators associated with airway inflammation. The most direct manner in which a given mediator can activate a C-fiber terminal is through interacting with its receptor expressed in the terminal membrane. The agonist-receptor interaction then must lead to the opening (or potentially closing) of ion channels that lead to a membrane depolarization. This depolarization is referred to as a generator potential. If, and only if, the generator potential reaches the voltage necessary to activate voltage-gated sodium channels, action potentials are initiated and conducted to the central terminals within the CNS. Therefore, there are three target areas to block the inflammatory mediator induced activation of C-fiber terminals. First, at the level of the mediator-receptor interaction, secondly at the level of the generator potential, and third at the level of the voltage-gated sodium channels. Here we provide a brief overview of each of these therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=85062880049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062880049&partnerID=8YFLogxK

U2 - 10.1016/j.pupt.2019.03.002

DO - 10.1016/j.pupt.2019.03.002

M3 - Review article

VL - 56

SP - 15

EP - 19

JO - Pulmonary Pharmacology and Therapeutics

JF - Pulmonary Pharmacology and Therapeutics

SN - 1094-5539

ER -